Alpine Immune Sciences Inc reports results for the quarter ended in December - Earnings Summary

Alpine Immune Sciences

23/03/2023 21:01

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 41 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 27 cents per share.
    * Revenue fell 38.7% to $2.78 million from a year ago;
analysts
expected $10.96 million. 
    * Alpine Immune Sciences Inc's reported EPS for the quarter
was a
loss of 41 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alpine Immune Sciences Inc shares had risen by 7.6% this
quarter.
    * The company reported a quarterly loss of $18.86 million.
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $16.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 23 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.27          -0.41          Missed
 Sep. 30 2022      -0.10          -0.42          Missed
 Jun. 30 2022      -0.39          -0.60          Missed
 Mar. 31 2022      -0.19          -0.25          Missed